Table 4 Cause of discontinuation of the study drugs in both groups
|  | Vancomycin (n = 54) | Teicoplanin (n = 62) |
|---|---|---|
Clinical failure | 10 (18.5%) | 25 (40.3%) |
Azotemia | 8 (14.8%) | 0 (0.0%) |
Elevated liver function test | 2 (3.7%) | 0 (0.0%) |
Skin rash | 1 (1.9%) | 1 (1.6%) |
Eosinophilia | 1 (1.9%) | 0 (0.0%) |
Thrombocytopenia | 1 (1.9%) | 0 (0.0%) |